Introduction
Irritable bowel syndrome (IBS) is a vague term for a variety of diseases causing discomfort in the gastro-intestinal tract which causes great morbidity in the population. IBS is also called by many names, among them colitis, mucous colitis, spastic colon, or spastic bowel are few. It is a functional bowel disorder characterized by chronic abdominal pain, discomfort, bloating and alteration of bowel habits in the absence of any organic cause.
[1] Certain psychological conditions are also more common in those with IBS. Diarrhea or constipation may predominate, or they may alternate (classified as IBS-D, IBS-C or IBS-A, respectively). IBS may begin after an infection (post-infectious, IBS-PI), a stressful life event, or onset of maturity without any other medical indicators.
[2] IBS affects 15-20% of Indian population. [3] It occurs more often in women than in men and it begins before the age of 35 in about 50% of people. [4] Psychological factors like stress, anxiety etc., plays an important role in the manifestation of IBS. [5] IBS is relatively a recent concept and as such is a new entry into the realm of clinical medicine itself. As there is no single disorder in Ayurveda which can be exactly co-relate with IBS because Ayurveda is based entirely on different basic principles. Some conditions in particular, quite practically similar with IBS in their clinical picture. These are Atisara, [6] 
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Bilvadileha
Bilvadileha was prepared by Arya Vaidya Sala, Kottakkal -676 503, Kerala, India. The ingredients and the parts used are given in Table 1 . 
Pattern of study
Ethical clearance
The study was approved by Institutional Ethics Committee (Ref PGT/7-A/Ethics/210-11/1858).
Eligibility criteria
1. Patients of either sex with age between 18 and 65 years 2. Known case of IBS as per Rome III criteria: [12] (Symptoms of recurrent abdominal pain or discomfort and a marked change in bowel habit for at least 6 months, with symptoms experienced on at least 3 days/month in the last 3 months associated with two or more of the following:
• Pain is relieved by defecation • Onset associated with change of frequency of stools • Onset associated with a change in form (appearance) of stools. 3. Willing and able to participate in the study. 
Exclusion criteria
Investigation
Routine investigations were done, before (to rule out any other pathology) and after treatment (to assess any untoward effect of trial drug during the regimen).
Hematology
Hemoglobin, total leucocyte count, differential leucocyte count (neutrophil, eosinophil, basophil, lymphocytes, monocytes), erythrocyte sedimentation rate.
Bio-chemistry
Blood sugar (fasting, PP), HbA1c, blood urea, serum uric acid, mg/dl, serum creatinine, serum glutamic oxaloacetic transaminase (AST), serum glutamic-pyruvic transaminase.
(ALT), total protein, serum albumin, serum globulin, A/G ratio, serum bilirubin, conjugated bilirubin, unconjugated bilirubin, serum ALP.
Stool examination (Microscopic)
Parasites (ova/cyst), mucous, vegetative cells, occult blood.
This disease being a functional disorder, rest of the biochemical and stool examination were conducted to rule out the exclusion criteria and after treatment the safety profile of the drug.
Interventions
Bilvadileha has been administered to the patients at the dose of 10 g twice a day orally after food with luke warm water for the duration of 12 weeks.
Methods of assessment
The assessment of IBS was done at the interval of 14 days on the basis of relief in chief complaints of IBS, disease specific Ayurvedic parameters and IBS severity score. [13] 
Observations and Results
A total of 51 patients were registered. Out of which 5 were drop out (Out of 5 patients drop out, 4 got transferred at another station. Cause of drop out for one patient was unknown and 46 completed the treatment [ Table 2 ]. All the patients were complaining about chronic and recurrent abdominal pain (100%). Abdominal bloating was found in 96.08%; IBS-C in 1.96%; IBS-D in 98.04%; Passage of mucus in 94.12%; Urgency of bowel movements in 88.24% patients [ Table 3 ].
In the present study, Udara Shula (Pain in abdomen), Anaha (Distention of the abdomen) and Udara Atopa (Tympanitis) was found in 100% patients whereas Pravahana (Tenesmus) in 96.08% patients, Mala Tyaga Asantushti (dissatisfaction after defecation) in 98.04% patients, Mala Durgandha (Foul odor of stool) in 74.51% patients, Bhojanopranta Mala Tyaga (Defecation after taking meals) in 80.39% patients and Guda Shula (Pain in the perianal region) was found in 41.18% patients [ Table 4 ].
After completion of therapy, chronic and recurrent abdominal pain improved by 67.09%, Abdominal bloating by 100%; IBS-D by 86.96%, passage of mucus by 100%; Urgency of bowel movements by 97.50%; Feeling of incomplete evacuation by 89.13% [ Table 5 ]. All these improvements were statistically highly significant (P < 0.001). Bivadi leha has shown 95.65% improvement in Pravahana. Udara Shula was improved by 67.39%; Anaha (Distention of the abdomen) by 93.48%; Mala tyaga Santushti (Satisfaction after defecation) by 89.13%; Kapha Nihssarana (Mucus in stool) by 100%; Udara Atopa by 97.83%; Mala Durgandha (Foul odour of stool) by 100%; Bhojanopranta Mala Tyaga by 100%; Guda Shula by 67.39% [ Table 6 ]. All these improvements were also statistically highly significant (P < 0.001). Effect of therapy on IBS severity score showed a relief of 64.59% that was statistically highly significant (P < 0.001) [ Table 7 ]. In stool, no any significant pathological changes were seen in before and after treatment stool examination.
to treatment and 2 (4.34%) patients reported no response to the treatment [ Table 8 ].
Discussion
All the cardinal symptoms and associated symptoms along with IBS severity score improved in a statistically highly significant manner (P < 0.001). Bilva roots are the main ingredient of the formulation Bilvadileha. The roots are sweet, astringent, bitter and febrifuge; useful in diarrhea, dysentery, dyspepsia, gastralgia, palpitation, seminal weakness, uropathy, vomiting, intermittent fever, swellings and gastric irritability in infants. [14] Vitiation Thus, due to different properties of its ingredients, Bilvadileha has properties like: Tridoshahara, Deepana, Pachana, Amanashaka, Grahi, Vibandhahara and Vatanulomana which checks the Samprapti (pathogenesis) and pacify the symptoms of IBS. Pharmacological activities such as antidiarrheal, [15] antidysentry, antibacterial, antiprotozoal, antispasmodic, antidepressant, antifungal, antigiardiasis, anthelmintic, antispasmodic, anti-inflammatory, [16] carminatives etc., check the IBS-PI. Having Rasayana effect, relieve the psychological factors such as anxiety fear etc., it may enhance the Bala of Deha and Indriya.
Conclusion
On the basis of this study, it can be concluded that the trial drug Bilvadileha is found to be effective in reliving symptoms of IBS. There was no adverse drug reaction seen during the period of trial. Further studies can be should be carried out with larger sample size in different places with a standard control drug in order to obtain more data the effect of this novel drug compound in management IBS. 
